Cadence, Inc., a leading provider of contract manufacturing solutions for the MedTech and Pharma industries, proudly celebrates our 40th anniversary in 2025. Established in July 1985 by engineer Martin Lightsey, Cadence has grown into a vertically integrated global partner, committed to advancing patient outcomes in collaboration with its OEM customers. The company offers comprehensive contract manufacturing services from initial design and development through manufacturing and full supply chain management of medical devices worldwide.
“Forty years ago, Cadence began with a simple yet powerful vision to provide custom solutions to OEMs through engineering and innovation,” stated Cadence’s President and CEO, Rob Werge. “Today, we are a highly differentiated provider to MedTech and Pharma OEMs because of our commitment to supporting our customers’ success; however, nothing would be possible without the great team of people at Cadence.”
The company now operates eight facilities across the U.S. and Costa Rica and employs approximately 800 people. Cadence delivers a wide range of capabilities from finished device assembly and packaging to nearshore operations, CNC grinding, precision machining, metal stamping, deep draw stamping, metal injection molding (MIM), laser processing, and plastic injection molding.
These capabilities support a diverse set of surgical end markets, including robotic-assisted surgery (RAS) and minimally invasive surgery (MIS), while also driving deeper collaboration into drug delivery and diagnostics with key customers. Through this vertically integrated approach, we can simplify and consolidate supply chains, providing efficient, cost-effective solutions that help bring life-changing medical technologies to market faster.
As part of our commitment to continuous improvement, Cadence has strengthened our New Product Introduction (NPI) process by building a world-class program management team and enhancing our manufacturability (DFM) expertise. In addition, the company has made significant investments in our manufacturing footprint – expanding operations and upgrading equipment – to meet growing demand and support increasing product complexity.
In early 2025, Cadence unveiled a refreshed brand that honors our rich heritage while reflecting our evolution as a trusted leader in MedTech manufacturing. As we enter our fifth decade, Cadence remains committed to delivering innovative solutions that improve patient outcomes and support the development of next-generation medical technologies.
“We’re proud of the journey that brought us here and even more excited about the future we are building,” added Werge.